Testosterone replacement therapy costs between $150 and $400 per month in 2026, depending on the treatment method and provider type. Injectable testosterone cypionate typically runs $30-80 monthly for medication plus $100-200 for monitoring visits, while testosterone gels cost $200-350 monthly. Insurance coverage varies significantly, with about 60% of major insurers covering TRT when medically necessary, requiring documented low testosterone levels below 300 ng/dL on two separate tests. Telehealth providers often charge $199-299 monthly for full packages including medication, lab work, and consultations. Compounded formulations through specialty pharmacies may cost $150-250 monthly. The total annual cost ranges from $1,800 to $4,800, making insurance coverage or HSA funds valuable for managing expenses. Patients should factor in quarterly lab monitoring costs of $100-200 per test when calculating their total TRT investment.
Key Takeaways
- Monthly TRT costs range from $150-400 depending on delivery method and provider
- Injectable testosterone is typically the most cost-effective option at $130-280 monthly
- Insurance covers TRT for about 60% of patients with documented medical necessity
- Telehealth providers offer competitive pricing with thorough care packages
- Annual monitoring adds $400-800 to total treatment costs
TRT Pricing Breakdown by Delivery Method
Injectable testosterone cypionate remains the most economical option for most patients. A 10ml vial costs $30-80 and typically lasts 8-10 weeks for standard 200mg weekly injections. Adding consultation fees and lab monitoring brings the monthly total to $130-280. Testosterone gels like AndroGel or Testim cost $200-350 monthly even with insurance copays, while testosterone pellets require $400-600 every 3-4 months plus the insertion procedure fee of $300-500. Compounded testosterone formulations through specialty pharmacies offer middle-ground pricing at $150-250 monthly. These preparations allow for customized dosing and can include additional compounds for enhanced absorption or reduced side effects. Many patients find compounded options provide better value than brand-name products.Insurance Coverage and Medical Necessity Requirements
Most insurance plans require strict criteria for TRT coverage in 2026. Patients need two morning testosterone readings below 300 ng/dL taken at least one week apart, plus clinical symptoms like fatigue, decreased libido, or mood changes documented by their physician. About 40% of initial TRT requests get denied on first submission, but appeals succeed in roughly 65% of cases when proper documentation is provided. Medicare covers TRT for documented hypogonadism but requires prior authorization and regular monitoring. Medicaid coverage varies by state, with 32 states providing coverage for medically necessary TRT. Patients paying out-of-pocket can use HSA or FSA funds for all TRT-related expenses including medications, lab work, and consultations.Alternative and Complementary Treatment Costs
Some patients explore peptide therapy as an alternative or complement to traditional TRT. Sermorelin therapy costs $200-400 monthly and may help stimulate natural testosterone production. Ipamorelin treatment runs $250-450 monthly and can support overall hormone optimization. These peptides work differently than direct testosterone replacement and may appeal to patients seeking more natural hormone support. BPC-157 therapy and TB-500 treatment are sometimes used alongside TRT for recovery and anti-aging benefits, adding $150-300 to monthly costs. While these combinations aren't medically necessary, some patients find the synergistic effects worthwhile for their quality of life goals.Frequently Asked Questions
Does insurance typically cover testosterone replacement therapy?
About 60% of major insurance plans cover TRT when medically necessary. You need documented low testosterone levels below 300 ng/dL on two separate morning tests, plus clinical symptoms. Prior authorization is usually required, and appeals are often necessary if initially denied. Coverage typically includes generic injectable testosterone but may exclude gels or pellets.
Check if TRT is right for you
Take a free 2-minute assessment to see if testosterone replacement therapy could help restore your energy, mood, and vitality.
Start Free Assessment →View data table
| Category | Patients Reporting Improvement (%) | Detail |
|---|---|---|
| Energy | 78 | Improves in 2-4 weeks |
| Mood | 72 | Stabilizes in 4-6 weeks |
| Libido | 82 | Returns in 3-6 weeks |
| Muscle | 65 | Visible at 3-4 months |
| Body Fat | 58 | Reduces over 6+ months |
What's the cheapest form of testosterone replacement therapy?
Injectable testosterone cypionate is the most cost-effective option, costing $30-80 for a 10-week supply of medication. Including doctor visits and lab monitoring, total monthly costs range from $130-280. Generic formulations are significantly cheaper than brand names like Depo-Testosterone, making injections the preferred choice for budget-conscious patients.
How often do I need lab work during TRT treatment?
Most doctors order lab work every 3-4 months during the first year, then every 6 months once levels stabilize. Each lab panel costs $100-200 and includes testosterone levels, estradiol, CBC, and liver function tests. Some providers include lab costs in monthly treatment packages, while others charge separately.
Are there ways to reduce TRT costs without insurance?
Yes, several options can lower out-of-pocket costs. Telehealth providers often offer competitive package deals. Compounding pharmacies may provide better pricing than commercial pharmacies. Patient assistance programs from manufacturers can reduce costs for qualifying patients. Using GoodRx or similar apps can provide discounts on medications at retail pharmacies.
Can I use HSA or FSA funds for testosterone replacement therapy?
Yes, TRT prescribed for diagnosed hypogonadism qualifies as a medical expense for HSA and FSA accounts. This includes the medication, doctor consultations, lab work, and monitoring visits. You'll need receipts and documentation that the treatment is medically necessary rather than for enhancement purposes.
Sources
- Mulhall JP, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423-432. PMID: 29601923
- Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. PMID: 29562364
- Corona G, et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytical study. Eur J Endocrinol. 2011;165(5):687-701. PMID: 21852391
- Hackett G, et al. British Society for Sexual Medicine Guidelines on Adult Testosterone Deficiency, With Statements for UK Practice. J Sex Med. 2017;14(12):1504-1523. PMID: 29198507
- Lunenfeld B, et al. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male. 2015;18(1):5-15. PMID: 25657080
- Nassar GN, Leslie SW. Physiology, Testosterone. StatPearls. 2023. PMID: 30252384
- Rajfer J. Relationship between testosterone and erectile dysfunction. Rev Urol. 2000;2(2):122-8. PMID: 16985775
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →